Count | |
2 | |
2 | |
1 | |
2 | |
1 | |
5 | |
Clofibric Acid/analogs & derivatives/pharmacology/therapeutic use | 1 |
Clofibric Acid/analogs & derivatives/pharmacokinetics/pharmacology | 1 |
Clofibric Acid/adverse effects/*analogs & derivatives/therapeutic use | 1 |
1 | |
2 | |
2 | |
1 | |
1 | |
3 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
25 | |
1 | |
8,11,14-Eicosatrienoic Acid/*analogs & derivatives/pharmacology | 1 |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
25 | |
1 | |
1 | |
16 | |
1 | |
1 | |
1 | |
5 | |
12 | |
5 | |
5 | |
1 | |
1 | |
1 | |
1 | |
1 | |
6 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
4 | |
1 | |
1 | |
1 | |
1 | |
Nordihydroguaiaretic Acid/*analogs & derivatives/*pharmacology | 2 |
1 | |
1 | |
Nordihydroguaiaretic Acid/*analogs & derivatives/pharmacology | 1 |
5 | |
1 | |
1 | |
8,11,14-Eicosatrienoic Acid/*analogs & derivatives/*pharmacology | 2 |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
8,11,14-Eicosatrienoic Acid/*analogs & derivatives/metabolism | 3 |
1 | |
1 | |
1 | |
2 | |
1 | |
5 | |
7 | |
2 | |
2 | |
2 | |
1 | |
1 | |